Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen(222 views visite) Perri F, Pisconti S, Conson M, Pacelli R, Della Vittoria Scarpati G, Gnoni A, D'Aniello C, Cavaliere C, Licchetta A, Cella L, Giuliano M, Schiavone C, Falivene S, Di Lorenzo G, Buonerba C, Ravo V, Muto P
Oncotargets Ther (ISSN: 1178-6930, 1178-6930linking), 2015 Jun 8; 8: 1345-1349.
Keywords Parole chiave: Adjuvant Treatment, Local Control, Three-Dimensional Conformal Radiotherapy, Thymoma, Toxicity,
Affiliations Affiliazioni: *** IBB - CNR ***
Medical Oncology Unit, POC S Annunziata, Taranto, Italy Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy Institute of Biostructures and Bioimaging, National Council of Research, Naples, Italy Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy Lester and Sue Smith Breast Center, Baylor College of Medicine, Houston, TX, United States Division of Oncology, Centro di riferimento Oncologico di Basilicata, IRCCS Rionero in Vulture, Potenza, Italy Department of Radiotherapy, Istituto Nazionale per la Cura dei Tumori-Fondazione G. Pascale. IRCCS di Napoli, Naples, Italy Commonwealth Scientific \& Industrial Research Organisation (CSIRO) Consiglio Nazionale delle Ricerche (CNR) Fdn G Pascale IRCCS Napoli
References Riferimenti: National Comprehensive Cancer Network, NCCN clinical practice guidelines in oncology, , http://www.nccn.org/professionals/physician_gls/f_guidelines.asp, (NCCN guidelines version I. 2014). Accessed February 20, 201
Eng, T.Y., Fuller, C.D., Jagirdar, J., Bains, Y., Thomas, C.R., Jr., Thymic carcinoma: State of the art review (2004) Int J Radiat Oncol Biol Phys., 59 (3), pp. 654-664
Koppitz, H., Rockstroh, J.K., Schüller, H., State-of-the-art classification and multimodality treatment of malignant thymoma (2012) Cancer Treat Rev., 38 (5), pp. 540-548
Kondo, K., Optimal therapy for thymoma (2008) J Med Invest., 55 (1-2), pp. 17-28
Gomez, D., Komaki, R., Yu, J., Ikushima, H., Bezjak, A., Radiation therapy definitions and reporting guidelines for thymic malignancies (2011) J Thorac Oncol., 6 (7), pp. S1743-S1748
Utsumi, T., Shiono, H., Kadota, Y., Postoperative radiation therapy after complete resection of thymoma has little impact on survival (2009) Cancer., 115 (23), pp. 5413-5420
Korst, R.J., Kansler, A.L., Christos, P.J., Mandal, S., Adjuvant radiotherapy for thymic epithelial tumors: A systematic review and meta-analysis (2009) Ann Thorac Surg., 87 (5), pp. 1641-1647
Eng, T.Y., Thomas, C.R., Jr., Radiation therapy in the management of thymic tumors (2005) Semin Thorac Cardiovasc Surg., 17 (1), pp. 32-40
Quintanilla-Martinez, L., Wilkins, E.W., Jr., Choi, N., Efird, J., Hug, E., Harris, N.L., Thymoma. Histologic subclassification is an independent prognostic factor (1994) Cancer., 74 (2), pp. 606-617
Ruffini, E., Mancuso, M., Oliaro, A., Recurrence of thymoma: Analysis of clinicopathologic features, treatment, and outcome (1997) J Thorac Cardiovasc Surg., 113 (1), pp. 55-63
Rena, O., Papalia, E., Oliaro, A., Does adjuvant radiation therapy improve disease-free survival in completely resected Masaoka stage II thymoma? (2007) Eur J Cardiothorac Surg., 31 (1), pp. 109-113
Mangi, A.A., Wright, C.D., Allan, J.S., Adjuvant radiation therapy for stage II thymoma (2002) Ann Thorac Surg., 74 (4), pp. 1033-1037
Haniuda, M., Morimoto, M., Nishimura, H., Kobayashi, O., Yamanda, T., Iida, F., Adjuvant radiotherapy after complete resection of thymoma (1992) Ann Thorac Surg., 54 (2), pp. 311-315
Yan, J., Liu, Q., Moseley, J.N., Adjuvant radiotherapy for stages II and III resected thymoma: A single-institutional experience (2014) Am J Clin Oncol., , In press
Sugie, C., Shibamoto, Y., Ikeya-Hashizume, C., Invasive thymoma: Postoperative mediastinal irradiation, and low-dose entire hemithorax irradiation in patients with pleural dissemination (2008) J Thorac Oncol., 3 (1), pp. 75-81
Komaki, R., Gomez, D.R., Radiotherapy for thymic carcinoma: Adjuvant, inductive, and definitive (2014) Front Oncol., 3, p. 330
Adjuvant treatment in patients at high risk of recurrence of thymoma: efficacy and safety of a three-dimensional conformal radiation therapy regimen
Petraglia F, Singh AA, Carafa V, Nebbioso A, Conte M, Scisciola L, Valente S, Baldi A, Mandoli A, Petrizzi VB, Ingenito C, De Falco S, Cicatiello V, Apicella I, Janssen-megens EM, Kim B, Yi G, Logie C, Heath S, Ruvo M, Wierenga ATJ, Flicek P, Yaspo ML, Della Valle V, Bernard O, Tomassi S, Novellino E, Feoli A, Sbardella G, Gut I, Vellenga E, Stunnenberg HG, Mai A, Martens JHA, Altucci L * Combined HAT/EZH2 modulation leads to cancer-selective cell death(187 visite) Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2018 May 22; 9(39): 25630-25646. Impact Factor:5.008 DettagliEsporta in BibTeXEsporta in EndNote
152 Records (138 escludendo Abstract e Conferenze). Impact factor totale: 547.573 (506.527 escludendo Abstract e Conferenze). Impact factor a 5 anni totale: 553.813 (511.299 escludendo Abstract e Conferenze).
Last modified by Ultima modifica di Marco Comerci on in data Sunday 12 July 2020, 13:14:49 222 views visite. Last view on Ultima visita in data Friday 18 December 2020, 17:18:22